Germany's Merck KGaA Raises Outlook on Robust Results, Easing Currency Headwinds

By Adria Calatayud

Germany's Merck KGaA raised its full-year guidance for the second quarter in a row, citing a robust performance and easing foreign-exchange headwinds.

The German life-sciences and chemicals group said Thursday that it now expects net sales for the full year to range from 21 billion to 21.8 billion euros ($24.26 billion-$25.19 billion), with organic growth of 1% to 3%. It had previously forecast sale to be flat or grow up to 3% organically, resulting in revenue of 20.4 billion to 21.4 billion euros.

The company anticipates earnings before interest, taxes, depreciation and amortization excluding one-time items to be between 5.9 billion and 6.3 billion euros, with growth of up to 3%. This compares with its previous guidance of 5.7 billion to 6.1 billion euros, with an organic performance ranging from a 2% fall to a 2% rise.

Merck, which already lifted its full-year outlook alongside first-quarter results, said this reflected abating foreign-exchange headwinds and expectations of stronger demand in the life-science and electronics markets, together with resilience in its healthcare operations.

"Our second-quarter performance confirms continued momentum from important growth drivers across all the industries we serve," Chief Executive Kai Beckmann said.

Write to Adria Calatayud at adria.calatayud@wsj.com

(END) Dow Jones Newswires

August 06, 2026 01:22 ET (05:22 GMT)